Visterra

Visterra is a clinical-stage biotechnology company dedicated to developing innovative antibody-based therapies for the treatment of kidney diseases and other difficult-to-treat conditions. Our proprietary technology platform enables the design and engineering of precision antibody-based product candidates that specifically bind to and modulate key disease targets. By applying this technology to disease targets that are not adequately addressed by traditional treatment methods, we are building a robust pipeline of novel therapies for patients with unmet needs.